Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Levosalbutamol Hydrochloride Nebuliser Solution

Approval Number

国药准字H20253611

Company山西阳和医药技术有限公司

Registration Date

March 11, 2025

Drug Information

Generic Name

盐酸左沙丁胺醇雾化吸入溶液

Dosage Form

吸入制剂

Strength

按C₁₃H₂₁NO₃计 3ml：0.63mg

Drug Type

化学药品

Registration Date

March 11, 2025

Company Information

Applicant Company

Company Name山西阳和医药技术有限公司

Company Address

山西省大同经济技术开发区医药工业园区二园区通源街909号

Manufacturing Company

Company Name山西国润制药有限公司

Company Address

山西省大同市阳高西北街6号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

盐酸左沙丁胺醇雾化吸入溶液 - NMPA 批准文号 | MedPath